Health1 min read

STAT+: Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more

By · Via STAT Health · Published by Everything Blog

In short

Novartis recently informed neurologists about seven previously undisclosed tumor cases detected in pediatric patients who received its spinal muscular atrophy gene therapy. The findings, now classified as a potential safety signal, are undergoing review by regulatory authorities following public confirmation by the advocacy group SMA Europe. In the United States, four recent appointees to the U.S. Preventive Services Task Force received conflict-of-interest waivers despite holding stock in relevant manufacturers. This panel plays a critical role in issuing healthcare recommendations that directly dictate insurer coverage mandates for procedures like colonoscopies and depression screenings.

Key points

  • The discovery of tumors following Novartis spinal muscular atrophy treatment is being for…: The discovery of tumors following Novartis spinal muscular atrophy treatment is being formally evaluated as an emerging safety signal.
  • Conflict-of-interest waivers were granted to allow four federal task force members to ser…: Conflict-of-interest waivers were granted to allow four federal task force members to serve despite their relevant healthcare stock holdings.
  • Task force determinations carry substantial weight by legally guiding clinical standards…: Task force determinations carry substantial weight by legally guiding clinical standards and mandating insurance coverage for preventive medical services.

Sources checked by our analysis pipeline: 1

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape, although we do plan to escort Mrs. Pharmalot to a sing-a-long, attend a food crawl, and promenade with the official mascots. We also hope to find time to indulge in another listening party where the rotation will likely include this, this, this, this and this. And what about you? This is a lovely time of year to appreciate the great outdoors, specifically a stroll or jalopy ride to gaze at the turning of the leaves. If the weather fails to cooperate, you could catch up on your reading or take in a moving picture show. Or now that the elections are over in the U.S., you may want to place a bet on what the future holds. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Novartis has acknowledged seven previously unknown instances in which tumors…

Health